Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in Amyotrophic Lateral Sclerosis
NCT01906658Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jul 2013
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of repository corticotropin injection in amyotrophic lateral sclerosis (ALS), sponsored by Mallinckrodt Pharmaceuticals. Started Jul 2013; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01906658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906658.